InvaTech Pharma Solutions Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle recall — FDA D-0115-2021
Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing.